Literature DB >> 21034609

Retinopathy of prematurity: an epidemic in the making.

Graham E Quinn1, Clare Gilbert, Brian A Darlow, Andrea Zin.   

Abstract

OBJECTIVE: To explore the etiology, incidence and methods to prevent and treat severe retinopathy of prematurity (ROP), which is rapidly becoming a threat to the vision of babies in areas of the world where increasing numbers of premature babies are surviving. DATA SOURCES: The data used in this review were mainly from Medline and PubMed published in English. The search term was "retinopathy of prematurity and premature birth". STUDY SELECTION: We discuss the historical perspectives, prevalence and incidence, classification and treatment methods of ROP in premature babies.
RESULTS: Peripheral retinal ablation for eyes with severe ROP can help prevent progression to blindness and several large clinical trials have shown the effectiveness of this treatment in high risk eyes. As a greater proportion of VLBW and ELBW babies survive, the population of babies at risk increases. In various regions of the world, different identification criteria are used to determine which babies are at risk of blindness in order to provide timely diagnostic examinations and treatment as needed. Methods for preventing ROP include better ante-natal and obstetric care leading to a reduction in the rate of prematurity, the use of ante-natal corticosteroids, and better neonatal care practices. Recent developments have indicated that management of oxygen supplementation is important for the prevention of severe ROP; however, there is not yet known what oxygen saturation target should be adopted. Sepsis increases severe ROP in very preterm infants. Genetic associations and a telemedicine approach may be explored to detect ROP. Treatment of anti-VEGF therapy are potentially useful in eyes with severe ROP, but long term effects are not yet known and such treatment should be used with great caution.
CONCLUSIONS: ROP is a potentially binding disease for premature babies which is becoming more prevalent with the development improving neonatal services in many countries in recent years. High priority should be placed on developing approaches to prevent ROP blindness by reducing preterm birth, improving care of premature babies in neonatal care units, and providing adequate ophthalmological services in those regions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034609

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  22 in total

1.  Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix.

Authors:  Edgar Hernandez-Andrade; Roberto Romero; Hyunyoung Ahn; Youssef Hussein; Lami Yeo; Steven J Korzeniewski; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2012-03-16

2.  Spontaneous regression of retinopathy of prematurity: incidence and predictive factors.

Authors:  Rui-Hong Ju; Jia-Qing Zhang; Xiao-Yun Ke; Xiao-He Lu; Li-Fang Liang; Wu-Jun Wang
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  SiRNA silencing of VEGF, IGFs, and their receptors in human retinal microvascular endothelial cells.

Authors:  Yona Nicolau; Fayez Bany-Mohammed; Charles L Cai; Jacob V Aranda; Kay D Beharry
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

4.  Retinopathy of prematurity and brain damage in the very preterm newborn.

Authors:  Elizabeth N Allred; Antonio Capone; Anthony Fraioli; Olaf Dammann; Patrick Droste; Jay Duker; Robert Gise; Karl Kuban; Alan Leviton; T Michael O'Shea; Nigel Paneth; Robert Petersen; Michael Trese; Kathleen Stoessel; Deborah Vanderveen; David K Wallace; Grey Weaver
Journal:  J AAPOS       Date:  2014-06       Impact factor: 1.220

5.  Case series of infants presenting with end stage retinopathy of prematurity to two tertiary eye care facilities in Mexico: underlying reasons for late presentation.

Authors:  Luz C Zepeda-Romero; Alonso Meza-Anguiano; Juan C Barrera-de León; Eusebio Angulo-Castellanos; Marco A Ramirez-Ortiz; José A Gutiérrez-Padilla; Clare E Gilbert
Journal:  Matern Child Health J       Date:  2015-06

6.  One-year experience in the retinopathy of prematurity: frequency and risk factors, short-term results and follow-up.

Authors:  Sariaydin Mehmet; Atlihan Fusun; Calkavur Sebnem; Olukman Ozgur; Ercan Gulten; Ozturk Arif Taylan; Kaya Kilic Fatma; Gokaslan Filiz; Altinyaprak Derya; Malatyali Rana
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

7.  Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside.

Authors:  Michelle T Cabrera; Sharon F Freedman; Mary Elizabeth Hartnett; Sandra S Stinnett; Bei Bei Chen; David K Wallace
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Nov-Dec       Impact factor: 1.300

8.  Scleral buckling surgery for stage 4A and 4B retinopathy of prematurity in critically ill neonates.

Authors:  Eleni Papageorgiou; Konstantina Riri; Dimitrios Kardaras; Ioanna Grivea; Asimina Mataftsi; Evangelia E Tsironi; Sofia Androudi
Journal:  Int Ophthalmol       Date:  2021-11-01       Impact factor: 2.031

9.  Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.

Authors:  Hembindu Chintala; Haibo Liu; Rahul Parmar; Monika Kamalska; Yoon Ji Kim; David Lovett; Maria B Grant; Brahim Chaqour
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

10.  Screening for retinopathy of prematurity: a report from upper Egypt.

Authors:  Mahmoud M Nassar
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.